Prescription drug · ANDA
Dofetilide NDC 42794-046
Dofetilide 500 ug/1 · Capsule · Oral · Sigmapharm Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42794-046-10 | 42794004610 | 60 CAPSULE in 1 BOTTLE, PLASTIC (42794-046-10)Marketed from Jun 11, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dofetilide
- Generic name (nonproprietary)
- dofetilide
- Active ingredients
- Dofetilide — 500 ug/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Sigmapharm Laboratories, LLCNDC labeler code 42794
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207746
- Marketing start
- Listing expires
- Identifiers
- Product ID 42794-046_f1f1f93d-aee6-246f-e053-2a95a90a9eeeSPL ID f1f1f93d-aee6-246f-e053-2a95a90a9eeeSPL set ID 0cb2ef7d-e35b-483b-9985-cfef99d7b96fRxCUI 310003, 310004, 310005UNII R4Z9X1N2NDUPC 0342794044106, 0342794045103, 0342794046100
- Pharmacologic class
- Antiarrhythmic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442794004610followed by a unit qualifier and the quantityPackage 42794-0046-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Maintenance of Normal Sinus Rhythm (Delay in AF/AFl Recurrence) Dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. Because dofetilide can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. In general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. Recurrence is expected in some …
Excerpt only. Read the full label for complete information.
About NDC 42794-046
- What is NDC 42794-046?
- 42794-046 is the product NDC for Dofetilide, Dofetilide 500 ug/1 capsule, listed with the FDA by Sigmapharm Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dofetilide.
- What is the active ingredient?
- Dofetilide.
- Who is the labeler?
- Sigmapharm Laboratories, LLC, NDC labeler code 42794. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dofetilide?
- 31 other product NDCs are listed under this name. See all Dofetilide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dofetilide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4738 | 70518-4738-0070518-4738-01 |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-4617 | 70518-4617-00 |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | EXELAN PHARMACEUTICALS, INC. | 76282-755 | 76282-0755-60 |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | EXELAN PHARMACEUTICALS, INC. | 76282-756 | 76282-0756-60 |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | EXELAN PHARMACEUTICALS, INC. | 76282-757 | 76282-0757-60 |
| Dofetilide | Dofetilide .125 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7522 | 00904-7522-08 |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7523 | 00904-7523-08 |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7524 | 00904-7524-08 |
| Dofetilide | Dofetilide .25 mg/1 | CapsuleOral | Dr. Reddy's Labratories Inc. | 75907-055 | 75907-0055-60 |
| Dofetilide | Dofetilide .5 mg/1 | CapsuleOral | Dr. Reddy's Labratories Inc. | 75907-054 | 75907-0054-60 |
Other NDCs under ANDA 207746
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dofetilide | Dofetilide 250 ug/1 | CapsuleOral | Sigmapharm Laboratories, LLC | 42794-045 |
| Dofetilide | Dofetilide 125 ug/1 | CapsuleOral | Sigmapharm Laboratories, LLC | 42794-044 |